Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study.
Corkum MT, Buyyounouski MK, Chang AJ, Chung HT, Chung P, Cox BW, Crook JM, Davis BJ, Frank SJ, Henriquez I, Horwitz EM, Hoskin P, Hsu IC, Keyes M, King MT, Kollmeier MA, Krauss DJ, Kukielka AM, Morton G, Orio PF 3rd, Pieters BR, Potters L, Rossi PJ, Showalter TN, Solanki AA, Song D, Vanneste B, Vigneault E, Wojcieszek PA, Zelefsky MJ, Kamrava M. Corkum MT, et al. Among authors: vanneste b. Radiother Oncol. 2023 Jul;184:109672. doi: 10.1016/j.radonc.2023.109672. Epub 2023 Apr 13. Radiother Oncol. 2023. PMID: 37059334
Dosimetric and Hematologic Implications of Prostate-Only Versus Whole Pelvic Radiotherapy: Results of the Multicentric Phase 3 PROPER Study.
Fonteyne V, Danckaert W, Ost P, Berghen C, Vandecasteele K, Vanneste B, Rans K, Liefhooghe N, Wallaert S, Paelinck L. Fonteyne V, et al. Among authors: vanneste b. Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231154088. doi: 10.1177/15330338231154088. Technol Cancer Res Treat. 2023. PMID: 37016933 Free PMC article. Clinical Trial.
Advances in radiotherapy and its impact on second primary cancer risk: A multi-center cohort study in prostate cancer patients.
Jahreiß MC, Hoogeman M, Aben KK, Dirkx M, Snieders R, Pos FJ, Janssen T, Dekker A, Vanneste B, Minken A, Hoekstra C, Smeenk RJ, Incrocci L, Heemsbergen WD. Jahreiß MC, et al. Among authors: vanneste b. Radiother Oncol. 2023 Jun;183:109659. doi: 10.1016/j.radonc.2023.109659. Epub 2023 Mar 30. Radiother Oncol. 2023. PMID: 37003369 Free article.
The influence of gastric filling instructions on dose delivery in patients with oesophageal cancer: A prospective study.
Van De Voorde L, Larue R, Persoon L, Öllers M, Nijsten S, Bosmans G, Berbée M, Swinnen A, van Elmpt W, Vanneste B, Verhaegen F, Lambin P. Van De Voorde L, et al. Among authors: vanneste b. Radiother Oncol. 2015 Dec;117(3):442-7. doi: 10.1016/j.radonc.2015.09.006. Epub 2015 Sep 10. Radiother Oncol. 2015. PMID: 26364885 Clinical Trial.
Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?
Vanneste BG, Van Limbergen EJ, van Lin EN, van Roermund JG, Lambin P. Vanneste BG, et al. Biomed Res Int. 2016;2016:6829875. doi: 10.1155/2016/6829875. Epub 2016 Dec 28. Biomed Res Int. 2016. PMID: 28116302 Free PMC article. Review.
85 results